Weil Gotshal & Manges and Wachtell Lipton Rosen & Katz are taking the key advisory roles as Sanofi-Aventis's multibillion-dollar bid for US biotechnology company Genzyme goes hostile. Weil Gotshal is acting for French pharma company Sanofi on its $18.5bn (£11.7bn) bid with a team including corporate partners Claude Serra in Paris and Michael Aiello in New York. Wachtell is advising Genzyme, with corporate partners Andrew Brownstein and Greg Ostling taking the key roles.
October 04, 2010 at 09:49 AM
1 minute read
The original version of this story was published on Legalweek
Weil Gotshal & Manges and Wachtell Lipton Rosen & Katz are taking the key advisory roles as Sanofi-Aventis’s multibillion-dollar bid for US biotechnology company Genzyme goes hostile.
Weil Gotshal is acting for French pharma company Sanofi on its $18.5bn (£11.7bn) bid with a team including corporate partners Claude Serra in Paris and Michael Aiello in New York.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
